APHA - Aphria Inc.

NYSE - NYSE Delayed Price. Currency in USD

Aphria Inc.

245 Talbot Street West
Suite 103
Leamington, ON N8H 3C4

IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees620

Key Executives

NameTitlePayExercisedYear Born
Mr. Irwin D. SimonInterim CEO & ChairmanN/AN/A1958
Mr. Carl A. MertonChief Financial OfficerN/AN/AN/A
Dr. Christelle Gedeon L.L.B., Ph.D.Chief Legal OfficerN/AN/AN/A
Mr. Victor NeufeldSpecial AdvisorN/AN/A1954
Mr. Cole CacciavillaniSpecial AdvisorN/AN/A1955
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Aphria Inc. produces and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis; and adult-use cannabis under the Solei, RIFF, Good Supply, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.

Corporate Governance

Aphria Inc.’s ISS Governance QualityScore as of October 4, 2019 is 8. The pillar scores are Audit: 1; Board: 8; Shareholder Rights: 6; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.